PJP (n = 78) | CMV-P (n = 34) | P-value | |
---|---|---|---|
Time between clinical onset and CT examination (days), median (IQR) | 6 (3, 10) | 5 (3, 13.25) | 0.99 |
Time between CT and bronchoscopy (days), median (IQR) | 5 (3, 7) | 3.50 (2, 6) | 0.07 |
GGO, n (%) | 100 | 100 | NS |
Mosaic perfusion, n (%) | 25 (32.05) | 10 (29.41) | 0.78 |
Crazy-paving pattern, n (%) | 7 (8.97) | 3 (8.82) | 0.98 |
Cons/GGO predominance, n (%) | 0.82 | ||
Cons | 2 (2.56) | 2(5.88) | |
GGO | 75 (96.15) | 32 (94.12) | |
Equal | 1 (1.28) | 0 | |
Cons/GGO distribution, n (%) | 0.06 | ||
Segmental | 6 (7.69) | 5 (14.71) | |
Non-segmental | 6 (7.69) | 7 (20.59) | |
Lobular | 66 (84.62) | 22 (64.71) | |
TIB, n (%) | 5 (6.41) | 5 (14.71) | 0.16 |
Bronchial wall thickening, n (%) | 27 (34.62) | 16 (47.06) | 0.21 |
Reticulation, n (%) | 45 (57.69) | 18 (52.94) | 0.64 |
LN enlargement, n (%) | 5 (6.41) | 5 (14.71) | 0.16 |
Pleural effusion, n (%) | 8 (10.26) | 8 (23.53) | 0.07 |
Cavity, n (%) | 2 (2.56) | 0 | 0.35 |
Cyst, n (%) | 13 (16.67) | 4 (11.76) | 0.51 |